BACKGROUND: Infants awaiting heart transplantation (HT) face the highest wait-list mortality among all children and adults listed for HT in the USA. We sought to determine the risk of death for infants <12 months old while awaiting HT in the current era, and to identify the principle risk factors associated with wait-list mortality. METHODS: We analyzed outcomes for all infants listed for HT in the USA from January 1999 to July 2006, using data reported to the U.S. Scientific Registry of Transplant Recipients. RESULTS: Of the 1,133 listed infants, 61% were <3 months of age, 80% were listed as Status 1A, 64% had a congenital heart disease (CHD) and 31% had cardiomyopathy. Of 724 infants with CHD, 25% were on prostaglandin (PG) and 27% had a history of prior surgery. By 6 months after listing, 23% died on the wait-list and 54% were transplanted. Multivariate factors associated with wait-list mortality were weight <3 kg (hazard ratio [HR] 1.4, 95% confidence interval [CI] 1.0 to 1.9), extracorporeal membrane oxygenation (ECMO) support (HR 5.6, CI 4.0 to 7.9), ventilator support (HR 2.1, 95% CI 1.6 to 2.8), CHD with PG support (HR 2.8, 95% CI 1.8 to 4.3), CHD without prior surgery (HR 2.8, 95% CI 1.9 to 3.9) and non-white race/ethnicity (HR 1.8, 95% CI 1.4 to 2.3). CONCLUSIONS: One in four infants listed for HT in the USA die before a donor heart can be identified. Wait-list mortality is associated with weight <3 kg, level of invasive support and CHD, but not listing status, which captures medical urgency poorly. Measures to expand infant organ donation, especially among neonates, are urgently needed.
BACKGROUND:Infants awaiting heart transplantation (HT) face the highest wait-list mortality among all children and adults listed for HT in the USA. We sought to determine the risk of death for infants <12 months old while awaiting HT in the current era, and to identify the principle risk factors associated with wait-list mortality. METHODS: We analyzed outcomes for all infants listed for HT in the USA from January 1999 to July 2006, using data reported to the U.S. Scientific Registry of Transplant Recipients. RESULTS: Of the 1,133 listed infants, 61% were <3 months of age, 80% were listed as Status 1A, 64% had a congenital heart disease (CHD) and 31% had cardiomyopathy. Of 724 infants with CHD, 25% were on prostaglandin (PG) and 27% had a history of prior surgery. By 6 months after listing, 23% died on the wait-list and 54% were transplanted. Multivariate factors associated with wait-list mortality were weight <3 kg (hazard ratio [HR] 1.4, 95% confidence interval [CI] 1.0 to 1.9), extracorporeal membrane oxygenation (ECMO) support (HR 5.6, CI 4.0 to 7.9), ventilator support (HR 2.1, 95% CI 1.6 to 2.8), CHD with PG support (HR 2.8, 95% CI 1.8 to 4.3), CHD without prior surgery (HR 2.8, 95% CI 1.9 to 3.9) and non-white race/ethnicity (HR 1.8, 95% CI 1.4 to 2.3). CONCLUSIONS: One in four infants listed for HT in the USA die before a donor heart can be identified. Wait-list mortality is associated with weight <3 kg, level of invasive support and CHD, but not listing status, which captures medical urgency poorly. Measures to expand infant organ donation, especially among neonates, are urgently needed.
Authors: J Timothy Baldwin; Harvey S Borovetz; Brian W Duncan; Mark J Gartner; Robert K Jarvik; William J Weiss; Tracey R Hoke Journal: Circulation Date: 2006-01-03 Impact factor: 29.690
Authors: Lori J West; Tara Karamlou; Anne I Dipchand; Stacey M Pollock-BarZiv; John G Coles; Brian W McCrindle Journal: J Thorac Cardiovasc Surg Date: 2006-02 Impact factor: 5.209
Authors: Mark M Boucek; Paul Aurora; Leah B Edwards; David O Taylor; Elbert P Trulock; Jason Christie; Fabienne Dobbels; Axel O Rahmel; Berkeley M Keck; Marshall I Hertz Journal: J Heart Lung Transplant Date: 2007-08 Impact factor: 10.247
Authors: W R Morrow; D Naftel; R Chinnock; C Canter; M Boucek; V Zales; D C McGiffin; J K Kirklin Journal: J Heart Lung Transplant Date: 1997-12 Impact factor: 10.247
Authors: M R K Chrisant; D C Naftel; J Drummond-Webb; R Chinnock; C E Canter; M M Boucek; R J Boucek; S C Hallowell; J K Kirklin; W R Morrow Journal: J Heart Lung Transplant Date: 2005-05 Impact factor: 10.247
Authors: Christopher S D Almond; Ravi R Thiagarajan; Gary E Piercey; Kimberlee Gauvreau; Elizabeth D Blume; Heather J Bastardi; Francis Fynn-Thompson; T P Singh Journal: Circulation Date: 2009-01-26 Impact factor: 29.690
Authors: Stacey M Pollock-BarZiv; Brian W McCrindle; Lori J West; Cedric Manlhiot; Meghan VanderVliet; Anne I Dipchand Journal: J Heart Lung Transplant Date: 2007-10 Impact factor: 10.247
Authors: Paul A Checchia; Ranae Larsen; Ruchir Sehra; Noha Daher; Steven R Gundry; Anees J Razzouk; Leonard L Bailey Journal: Ann Thorac Surg Date: 2004-02 Impact factor: 4.330
Authors: Nishant D Patel; Eric S Weiss; Janet Scheel; Duke E Cameron; Luca A Vricella Journal: J Heart Lung Transplant Date: 2008-10 Impact factor: 10.247
Authors: Brody Wehman; Kristen A Stafford; Gregory J Bittle; Zachary N Kon; Charles F Evans; Keshava Rajagopal; Nicholas Pietris; Sunjay Kaushal; Bartley P Griffith Journal: Ann Thorac Surg Date: 2016-02-22 Impact factor: 4.330
Authors: Alessandro Caimi; Francesco Sturla; Bryan Good; Marco Vidotto; Rachele De Ponti; Filippo Piatti; Keefe B Manning; Alberto Redaelli Journal: J Biomech Eng Date: 2017-08-01 Impact factor: 2.097